Prevention of perioperative venous thromboembolism in children;Perioperative Thromboseprophylaxe bei Kindern

Wiener Medizinische Wochenschrift

Volumn 159, Issue 19-20, 2009, Pages 481-486

  Streif, Werner ^a  

^a Universitatsklinik fur Kinder und Jugendheilkunde Innsbruck   (Austria)

Author keywords

Child; Drug therapy; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ARGATROBAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; DABIGATRAN ETEXILATE; DALTEPARIN; DANAPAROID; ENOXAPARIN; FONDAPARINUX; HEPARIN; HIRUDIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REVIPARIN; TINZAPARIN; UNCLASSIFIED DRUG; XARELTRO;

ADULT; APPENDECTOMY; BLEEDING; CARDIOVASCULAR RISK; CHILD; CIRCUMCISION; CLINICAL PRACTICE; COHORT ANALYSIS; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; HEMOSTASIS; HERNIOTOMY; HUMAN; IMMOBILIZATION; INCIDENCE; MEDICAL DECISION MAKING; MINOR SURGERY; PEDIATRIC SURGERY; PERIOPERATIVE PERIOD; PHYSICIAN; POSTTHROMBOSIS SYNDROME; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; THROMBOCYTOPENIA; VENOUS THROMBOEMBOLISM;

ADOLESCENT; AGE FACTORS; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; HUMANS; INFANT; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; POSTTHROMBOTIC SYNDROME; PRACTICE GUIDELINES AS TOPIC; PULMONARY EMBOLISM; RISK ASSESSMENT; SURGICAL PROCEDURES, OPERATIVE; VENOUS THROMBOSIS;

EID: 71149115636     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-009-0712-6     Document Type: Review

References (54)

1. AK Chan G deVeber P Monagle LA Brooker PM Massicotte 2003 Venous thrombosis in children J Thromb Haemost 1 7 1443 1455 10.1046/j.1538-7836.2003. 00308.x 1:STN:280:DC%2BD3szjvFOguw%3D%3D 12871279
2. S Parasuraman SZ Goldhaber 2006 Venous thromboembolism in children Circulation 113 2 e12 e16 10.1161/CIRCULATIONAHA.105.583773 16418440 (Pubitemid 43754362)
3. FR Rosendaal 1997 Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis Thromb Haemost 78 1 1 6 1:CAS:528: DyaK2sXktFemur4%3D 9198119
4. P Monagle M Adams M Mahoney K Ali D Barnard M Bernstein, et al. 2000 Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry Pediatr Res 47 6 763 766 10.1203/00006450- 200006000-00013 1:STN:280:DC%2BD3cvit1ejtA%3D%3D 10832734
5. C Barnes F Newall P Monagle 2002 Post-thrombotic syndrome Arch Dis Child 86 3 212 214 10.1136/adc.86.3.212 1:STN:280:DC%2BD387isFyqtw%3D%3D 11861250 (Pubitemid 34250873)
6. MS Vavilala AB Nathens GJ Jurkovich E Mackenzie FP Rivara 2002 Risk factors for venous thromboembolism in pediatric trauma J Trauma 52 5 922 927 10.1097/00005373-200205000-00017 11988660
7. MC Azu JE McCormack RJ Scriven JS Brebbia MJ Shapiro TK Lee 2005 Venous thromboembolic events in pediatric trauma patients: is prophylaxis necessary? J Trauma 59 6 1345 1349 10.1097/01.ta.0000196008.48461.47 16394907
8. WH Geerts D Bergqvist GF Pineo JA Heit CM Samama MR Lassen, et al. 2008 Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed) Chest 133 6 Suppl 381S 453S 10.1378/chest.08-0656 1:CAS:528:DC%2BD1cXptVKhsrg%3D 18574271 (Pubitemid 351894916)
9. P Monagle E Chalmers A Chan G deVeber F Kirkham P Massicotte, et al. 2008 Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed) Chest 133 6 Suppl 887S 968S 10.1378/chest.08-0762 1:CAS:528:DC%2BD1cXptVKhsLs%3D 18574281 (Pubitemid 351892979)
10. PC Jackson JM Morgan 2008 Perioperative thromboprophylaxis in children: development of a guideline for management Paediatr Anaesth 18 6 478 487 10.1111/j.1460-9592.2008.02597.x 18445200 (Pubitemid 351600204)
11. A Encke S Haas S Sauerland HH Abholz MW Beckmann C Bode, et al. 2009 S3-Leitlinie: Prophylaxe der venösen Thromboembolie (VTE) Vasa 38 S76 1 131 10.1024/0301-1526.38.S76.1
12. M Andrew B Paes M Johnston 1990 Development of the hemostatic system in the neonate and young infant Am J Pediatr Hematol Oncol 12 1 95 104 10.1097/00043426-199021000-00019 1:STN:280:DyaK3c7nvVGksg%3D%3D 2178462
13. M Andrew M David M Adams K Ali R Anderson D Barnard, et al. 1994 Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE Blood 83 5 1251 1257 1:STN:280:DyaK2c7mt1KhsQ%3D%3D 8118029
14. S Kuhle P Massicotte A Chan M Adams M Abdolell G de Veber, et al. 2004 Systemic thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation Service Thromb Haemost 92 4 722 728 1:CAS:528:DC%2BD2cXovVOlsLg%3D 15467901
15. W Streif M Andrew V Marzinotto P Massicotte AK Chan JA Julian, et al. 1999 Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients Blood 94 9 3007 3014 1:CAS:528:DyaK1MXntVSrsbg%3D 10556183
16. J Dubois F Rypens L Garel M David J Lacroix F Gauvin 2007 Incidence of deep vein thrombosis related to peripherally inserted central catheters in children and adolescents CMAJ 177 10 1185 1190 17978273
17. U Nowak-Gottl R von Kries U Gobel 1997 Neonatal symptomatic thromboembolism in Germany: two year survey Arch Dis Child Fetal Neonatal Ed 76 3 F163 F167 10.1136/fn.76.3.F163 1:STN:280:DyaK2szhvFSnsA%3D%3D 9175945
18. CH van Ommen H Heijboer HR Buller RA Hirasing HS Heijmans M Peters 2001 Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands J Pediatr 139 5 676 681 10.1067/mpd.2001.118192 1:STN:280: DC%2BD3MnmslOiuw%3D%3D 11713446 (Pubitemid 33097433)
19. M Andrew P Vegh M Johnston J Bowker F Ofosu L Mitchell 1992 Maturation of the hemostatic system during childhood Blood 80 8 1998 2005 1:STN:280:DyaK3s%2FgsVOlsA%3D%3D 1391957
20. MJ Rohrer BS Cutler E MacDougall JB Herrmann FA Anderson Jr HB Wheeler 1996 A prospective study of the incidence of deep venous thrombosis in hospitalized children J Vasc Surg 24 1 46 49 10.1016/S0741-5214(96)70143-X 1:STN:280:DyaK28zgsFahsg%3D%3D 8691526
21. D Tormene P Simioni P Prandoni F Franz P Zerbinati G Tognin, et al. 2002 The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study Blood 100 7 2403 2405 10.1182/blood-2002-04-1186 1:CAS:528:DC%2BD38XnvVGisL8%3D 12239149
22. P Simioni BJ Sanson P Prandoni D Tormene PW Friederich B Girolami, et al. 1999 Incidence of venous thromboembolism in families with inherited thrombophilia Thromb Haemost 81 2 198 202 1:CAS:528:DyaK1MXhvVGrtLo%3D 10063991
23. W Streif AR Borum B Paes L Berry L Xu M Andrew, et al. 2000 Influence of activated factor VII concentrates on thrombin generation in full-term and preterm neonates Blood Coagul Fibrinolysis 11 Suppl 1 S133 S134 1:CAS:528:DC%2BD3cXktlGitrY%3D 10850579
24. G Young M Albisetti M Bonduel L Brandao A Chan F Friedrichs, et al. 2008 Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies Circulation 118 13 1373 1382 10.1161/CIRCULATIONAHA.108.789008 18779442
25. O Rask E Berntorp R Ljung 2005 Risk factors for venous thrombosis in Swedish children and adolescents Acta Paediatr 94 6 717 722 10.1080/ 08035250510025815 16188774 (Pubitemid 40839800)
26. C Male JA Julian P Massicotte M Gent L Mitchell 2005 Significant association with location of central venous line placement and risk of venous thrombosis in children Thromb Haemost 94 3 516 521 1:CAS:528:DC%2BD2MXhtVaqur3P 16268465
27. MP Massicotte D Dix P Monagle M Adams M Andrew 1998 Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications J Pediatr 133 6 770 776 10.1016/S0022- 3476(98)70149-0 1:STN:280:DyaK1M%2FlvF2jsQ%3D%3D 9842042
28. C Male P Chait JS Ginsberg K Hanna M Andrew J Halton, et al. 2002 Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase Thromb Haemost 87 4 593 598 1:CAS:528:DC%2BD38Xjt1egt7k%3D 12008940
29. CH van Ommen H Heijboer EJ van den Dool BA Hutten M Peters 2003 Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome J Thromb Haemost 1 12 2516 2522 10.1046/j.1538-7836.2003.00465.x 1:CAS:528:DC%2BD2cXktFOlsLY%3D 14675086
30. AN Amin S Stemkowski J Lin G Yang 2008 Preventing venous thromboembolism in US hospitals: are surgical patients receiving appropriate prophylaxis? Thromb Haemost 99 4 796 797 1:CAS:528:DC%2BD1cXlsF2gtLs%3D 18392346
31. AK Kakkar BL Davidson SK Haas 2004 Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines J Thromb Haemost 2 2 221 227 10.1111/j.1538-7933. 2004.00588.x 1:STN:280:DC%2BD2c7gs1Sktw%3D%3D 14995982 (Pubitemid 40186034)
32. MP Massicotte M Sofronas G deVeber 2006 Difficulties in performing clinical trials of antithrombotic therapy in neonates and children Thromb Res 118 1 153 163 10.1016/j.thromres.2005.05.020 1:CAS:528:DC%2BD28XkslSntr8%3D 16009401
33. P Roderick G Ferris K Wilson H Halls D Jackson R Collins, et al. 2005 Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis Health Technol Assess 9 49 iii x 1:STN:280:DC%2BD2Mnls1GrsQ%3D%3D 16336844 1
34. W Wilson KA Taubert M Gewitz PB Lockhart LM Baddour M Levison, et al. 2007 Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation 116 15 1736 1754 10.1161/CIRCULATIONAHA.106.183095 17446442 (Pubitemid 47542239)
35. O Agu G Hamilton D Baker 1999 Graduated compression stockings in the prevention of venous thromboembolism Br J Surg 86 8 992 1004 10.1046/j.1365-2168.1999.01195.x 1:STN:280:DyaK1MzptVahtg%3D%3D 10460633 (Pubitemid 29387063)
36. J Hirsh TE Warkentin R Raschke C Granger EM Ohman JE Dalen 1998 Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety Chest 114 5 Suppl 489S 510S 10.1378/chest.114.5-Supplement.489S 1:CAS:528:DyaK1cXotVersLo%3D 9822059
37. M Andrew B Paes R Milner M Johnston L Mitchell DM Tollefsen, et al. 1987 Development of the human coagulation system in the full-term infant Blood 70 1 165 172 1:CAS:528:DyaL2sXlsleiu7k%3D 3593964
38. AK Chan L Black C Ing LR Brandao S Williams 2008 Utility of aPTT in monitoring unfractionated heparin in children Thromb Res 122 1 135 136 10.1016/j.thromres.2007.09.007 1:CAS:528:DC%2BD1cXlvVCmsro%3D 17976694 (Pubitemid 351606295)
39. F Newall L Johnston V Ignjatovic P Monagle 2009 Unfractionated heparin therapy in infants and children Pediatrics 123 3 e510 e518 10.1542/peds.2008- 2052 19221154
40. W Streif G Goebel AK Chan MP Massicotte 2003 Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients Arch Dis Child Fetal Neonatal Ed 88 5 F365 F370 10.1136/fn.88.5.F365 1:STN:280:DC%2BD3szpslKqug%3D%3D 12937038
41. D Dix M Andrew V Marzinotto K Charpentier S Bridge P Monagle, et al. 2000 The use of low molecular weight heparin in pediatric patients: a prospective cohort study J Pediatr 136 4 439 445 10.1016/S0022-3476(00)90005-2 1:CAS:528:DC%2BD3cXivFOgt7w%3D 10753240
42. P Massicotte JA Julian M Gent K Shields V Marzinotto B Szechtman, et al. 2003 An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial Thromb Res 109 2-3 85 92 10.1016/S0049-3848(03)00059-8 1:CAS:528:DC%2BD3sXjtFWgtrg%3D 12706636 (Pubitemid 36428758)
43. N Nohe A Flemmer R Rumler M Praun K Auberger 1999 The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases Eur J Pediatr 158 Suppl 3 S134 S139 10.1007/PL00014339 1:CAS:528:DC%2BD3cXpt1yqtA%3D%3D 10650853
44. CH van Ommen EJ van den Dool M Peters 2008 Nadroparin therapy in pediatric patients with venous thromboembolic disease J Pediatr Hematol Oncol 30 3 230 234 10.1097/MPH.0b013e31816356f8 1:CAS:528:DC%2BD1cXksVemt7w%3D 18376287
45. M Andrew V Marzinotto P Massicotte V Blanchette J Ginsberg P Brill-Edwards, et al. 1994 Heparin therapy in pediatric patients: a prospective cohort study Pediatr Res 35 1 78 83 10.1203/00006450-199401000-00016 1:STN:280:DyaK2c7otFelsQ%3D%3D 8134203 (Pubitemid 24004639)
46. S Kuhle P Eulmesekian B Kavanagh P Massicotte P Vegh LG Mitchell 2007 A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: a prospective cohort study Haematologica 92 2 244 247 10.3324/haematol.10616 1:CAS:528: DC%2BD2sXhtFGqurfI 17296576
47. A Greinacher 2009 Heparin-induced thrombocytopenia J Thromb Haemost 7 Suppl 1 9 12 10.1111/j.1538-7836.2009.03385.x 1:CAS:528:DC%2BD1MXpvV2jtbw%3D 19630757
48. T Severin AH Sutor 2001 Heparin-induced thrombocytopenia in pediatrics Semin Thromb Hemost 27 3 293 299 10.1055/s-2001-15259 1:CAS:528: DC%2BD3MXltFejtrg%3D 11446663 (Pubitemid 32550171)
49. D Spadone F Clark E James J Laster J Hoch D Silver 1992 Heparin-induced thrombocytopenia in the newborn J Vasc Surg 15 2 306 311 10.1067/mva.1992.33807 1:STN:280:DyaK387jvFCrug%3D%3D 1735891
50. T Severin B Zieger AH Sutor 2002 Anticoagulation with recombinant hirudin and danaparoid sodium in pediatric patients Semin Thromb Hemost 28 5 447 454 10.1055/s-2002-35285 1:CAS:528:DC%2BD38XovVCksL4%3D 12420240 (Pubitemid 35217490)
51. C Bidlingmaier HN Magnani M Girisch K Kurnik 2006 Safety and efficacy of danaparoid (Orgaran) use in children Acta Haematol 115 3-4 237 247 10.1159/000090941 1:CAS:528:DC%2BD28Xis1eqsbk%3D 16549902
52. Y Stirling 1995 Warfarin-induced changes in procoagulant and anticoagulant proteins Blood Coagul Fibrinolysis 6 5 361 373 10.1097/00001721-199507000-00001 1:CAS:528:DyaK2MXns1Wjtro%3D 8589201
53. S Moll 2004 Warfarin-induced skin necrosis Br J Haematol 126 5 628 10.1111/j.1365-2141.2004.05095.x 15327512 (Pubitemid 39221296)
54. W Geerts 2009 Prevention of venous thromboembolism: a key patient safety priority J Thromb Haemost 7 Suppl 1 1 8 10.1111/j.1538-7836.2009.03384.x 19630756